卖什么
The dynamic single-cell analysis company
商业模式拆解
买家：谁掌握预算？
未核实Immunotherapy R&D / cell therapy discovery and characterization leads at biopharma.
触发点：什么让他们现在购买？
Choosing which cell therapy candidates (e.g. CAR designs) to move into clinic, understanding clinical response and keeping manufacturing consistent.
工作流：什么输入变成什么输出？
Load cells in nanowell grids, run time-lapse microscopy (TIMING), apply neural-network detection to quantify migration, contact, killing and survival of thousands of single cells, then retrieve cells for scRNA-seq or flow cytometry.
经济账：省了什么，怎么收费？
未核实Likely fee-for-service assays plus instrument/platform access (cart page exists, listed on Scientist.com providers); no prices published.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2021 夏季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.